Gsk (GSK) EBITDA (2009 - 2026)
Gsk's EBITDA came in at $3.72 billion for the quarter ended Mar 31, 2026, down 2.9% from $3.83 billion a year earlier and down 68.9% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Gsk reported EBITDA of $21.48 billion, up 103.3% year-over-year; for the year ended Dec 31, 2025, it was $15.44 billion, up 72.4% from the prior year.
- EBITDA carries a five-year compound annual growth rate of 19.1% (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA was $8.96 billion in the year ended Dec 31, 2024 (-33.4%), $13.44 billion in the year ended Dec 31, 2023 (+10.6%), $12.15 billion in the year ended Dec 31, 2022 (+14.8%) and $10.58 billion in the year ended Dec 31, 2021 (+64.6%).
- The figure for the quarter ended Mar 31, 2026 represents the lowest quarterly EBITDA since the quarter ended Dec 31, 2024.
- Year-over-year, EBITDA increased in two of the last four quarters, with growth averaging 135.1%.
- The fastest year-over-year change in EBITDA over five years came in the quarter ended Dec 31, 2025 (growth of 504.2%), and the weakest in the quarter ended Dec 31, 2021 (a decline of 53.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Bn |
| Dec 31, 2025 | 11.96 Bn |
| Mar 31, 2025 | 3.83 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Mar 31, 2024 | 2.59 Bn |
| Dec 31, 2023 | 2.17 Bn |
| Mar 31, 2023 | 3.31 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Mar 31, 2022 | 3.64 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Mar 31, 2021 | 2.17 Bn |
| Dec 31, 2020 | 2.66 Bn |
| Mar 31, 2020 | 2.83 Bn |
| Dec 31, 2019 | 3.12 Bn |
| Sep 30, 2019 | 3.28 Bn |
| Mar 31, 2019 | 3.40 Bn |
| Dec 31, 2018 | 2.76 Bn |
| Mar 31, 2018 | 2.39 Bn |
| Dec 31, 2017 | 1.85 Bn |
| Mar 31, 2017 | 2.53 Bn |
API Access
Gsk EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();